Valuation: Haleon plc

Market Cap 31.91B 42.86B 37.22B 34.72B 60.19B 4,086B 61.24B 410B 161B 2,038B 161B 157B 6,744B P/E 2026 *
18.8x
P/E 2027 * 16.7x
Enterprise Value 38.8B 52.11B 45.25B 42.21B 73.18B 4,967B 74.45B 498B 195B 2,477B 196B 191B 8,199B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.22x
Free-Float
97.15%
Yield 2026 *
2.22%
Yield 2027 * 2.47%
1 day-0.28%
1 week-0.33%
Current month-0.28%
1 month+0.53%
3 months+5.29%
6 months-5.33%
Current year-3.34%
1 week 359.9
Extreme 359.9
384.2
1 month 354.1
Extreme 354.1
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-0.33%-0.85%+12.64% 43.08B
-2.39%-6.24%+47.10%+146.73% 1,024B
-0.76%-3.41%+52.04%+49.73% 618B
-2.33%-5.50%+25.55%+64.08% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-1.66%-1.89%+32.18%+37.17% 297B
-8.96%-9.23%+3.57%+3.64% 264B
-1.37%-5.71%-2.10%-44.43% 209B
-1.63%+0.75%+27.62%+64.43% 208B
+0.72%+1.42%+15.88%+73.30% 162B
Average -1.04%-1.22%+23.94%+43.92% 361.68B
Weighted average by Cap. -0.60%-2.14%+34.14%+68.88%

Financials

2026 *2027 *
Net sales 11.4B 15.31B 13.3B 12.4B 21.5B 1,459B 21.87B 146B 57.33B 728B 57.44B 56.23B 2,409B 11.89B 15.97B 13.87B 12.93B 22.42B 1,522B 22.81B 153B 59.79B 759B 59.9B 58.64B 2,512B
Net income 1.7B 2.28B 1.98B 1.84B 3.2B 217B 3.25B 21.77B 8.53B 108B 8.54B 8.36B 358B 1.93B 2.59B 2.25B 2.09B 3.63B 246B 3.69B 24.72B 9.68B 123B 9.7B 9.5B 407B
Net Debt 6.89B 9.25B 8.03B 7.49B 12.99B 882B 13.21B 88.43B 34.63B 440B 34.7B 33.96B 1,455B 6.4B 8.59B 7.46B 6.96B 12.06B 819B 12.27B 82.12B 32.16B 408B 32.22B 31.54B 1,351B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-08-03 GBX 362.30 -0.28% 18,642,450
26-07-31 GBX 363.30 -1.44% 25,724,593
26-07-30 GBX 368.60 -2.92% 27,282,182
26-07-29 GBX 379.70 -0.32% 36,335,259
26-07-28 GBX 380.90 +2.89% 29,790,922
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.623GBP
Average target price
4.178GBP
Spread / Average Target
+15.31%

Quarterly revenue - Rate of surprise